In this study, spinel-phase Zn2Ga3-xFe3+xGe0.75O8 (x = 0, 0.002, 0.004, 0.02, 0.04, 0.08, 0.2) and Zn2Ga2.98-xFe3+xCr0.02Ge0.75O8 (x = 0, 0.0004, 0.001, 0.002 0.003, 0.004) nanoparticles were prepared by one-step hydrothermal method in combination with vacuum annealing. For ZGGO: Fe3+ nanoparticles, the near infrared (NIR) emissions (∼725 nm) originate from the 4T1(4G)→6A1(6S) transition of Fe3+ occupying octahedral and tetrahedral sites of Ga3+. Furthermore, their afterglow time is more than 15 min and Fe3+ doping will influence the generation of antisite defects pair (GaZn0−ZnGa′). For Cr3+ and Fe3+ co-doped ZGGO nanoparticles with average size of ∼46 nm, the NIR persistent luminescence around ∼700 nm, originating from the 2E→4A2 and 4T2→4A2 transitions of Cr3+, can be observed and the afterglow time exceeds 850 min. With the increase of Fe3+ concentration, the afterglow intensity decreases due to the decreased number of (GaZn0−ZnGa′) defects and deeper traps. In particular, autofluorescence-free imaging and MR imaging were successfully realized by using ZGGO: Cr3+, Fe3+0.002 nanoparticles dispersed in the simulated biological fluid environments (H2O, SLS and HSA). Their clear afterglow images can be acquired within 3 min after the stoppage of the UV irradiation and their transversal relaxivity (r2) is in the range of 227–140 mM−1s−1, which is close to the conventional Feridex T2 agent (108 mM−1s−1). Our results suggest that ZGGO: Cr3+, Fe3+ nanoprobes have potential applications in the diagnosis and therapy of disease.
Read full abstract